STRESS GENES IN BRAIN ISCHEMIA

脑缺血中的应激基因

基本信息

项目摘要

Stress genes are induced in cells of the central nervous system (CNS) in response to ischemia, seizure, trauma and other stresses. The hsp7O family comprises a large group of related proteins including hsp70 (heat inducible), hsc70 (constitutive) and grp78 (glucose regulated, endoplasmic reticular). We have chosen to study this family, as they are among the most highly inducible and abundant stress proteins. Hsp70 protein and mRNA mapping has yielded insights into the pathophysiology of ischemia and other types of brain injury. Another exciting aspect of stress protein research is the finding that induction of such proteins, and hsp70 in particular, is associated with a resistance to subsequent injury. Thus, the study of the hsp7O family may contribute to the understanding of basic mechanisms of CNS injury, and may have implications for the therapy of stroke and other forms of CNS damage. In preliminary experiments, hsp7O-related sequences were sought in the brain by degenerate-primer PCR, in order to identify new members of the hsp7O family. Two such hsp70-related cDNA fragments were found, designated hsr1 and hsr2. Hsr1 codes for a peptide sequence which is highly similar to mitochondrial hsp70 family members (which have not been cloned in vertebrates) and dnaK the major bacterial hsp7O. It is constitutively expressed but may also be responsive to cell injury. Hsr2 codes for no hsp7O-related peptides and has no major open reading frame. Hsr2 likely represents the 3' or 5' flanking region of a gene unrelated to hsp70. Nevertheless, 1 minor and 2 major mRNA species hybridizing to hsr2 at high stringency were found to be upregulated during brain injury. Additional preliminary data on the responses of hsp7O, hsc7O and grp78 mRNA to focal ischemia suggested a differential failure of message accumulation in striatal ischemia, with grp78 message continuing to rise while hsp7O and hsc7O did not. This phenomenon did not occur in the cortex. The studies outlined in this proposal are directed towards the characterization of the hsp70 family and hsr2 in the normal and ischemic brain. Hsr1 and hsr2 will first be characterized by completing the sequencing of their full-length cDNAs and examination of their 5' promoter regions using library screening and PCR techniques. Specific antibodies to hsr1, hsr2, hsc70 and grp78 will be produced, and the tissue, cellular and subcellular distributions of hsr1 and hsr2 will be examined. Expression of hsr2 and all of the available hsp7O-related genes will be studied in normal brain,in vivo models of focal and global ischemia and in hyperthermic, hypoglycemic, anoxic and excitotoxic injury in cortical and cerebellar neurons and astrocytes in culture. Regional information on relative quantities and forms of expression of mRNA and protein will be obtained using Northern and Western analysis. Cellular and subcellular distributions will be examined by in situ hybridization and immunocytochemistry. Graded degrees of injury and time courses of expression will be studied.
应激基因在中枢神经系统(CNS)细胞中被诱导

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEPHEN M. MASSA其他文献

STEPHEN M. MASSA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEPHEN M. MASSA', 18)}}的其他基金

p75NTR ligands for ALS therapy
用于 ALS 治疗的 p75NTR 配体
  • 批准号:
    9974285
  • 财政年份:
    2019
  • 资助金额:
    $ 7.58万
  • 项目类别:
ShEEP request for Real-Time Quantitative PCR machine
ShEEP 要求提供实时定量 PCR 机
  • 批准号:
    9212034
  • 财政年份:
    2016
  • 资助金额:
    $ 7.58万
  • 项目类别:
Trk Ligands for Treatment of Traumatic Brain Injury
用于治疗创伤性脑损伤的 Trk 配体
  • 批准号:
    8736250
  • 财政年份:
    2010
  • 资助金额:
    $ 7.58万
  • 项目类别:
Trk Ligands for Treatment of Traumatic Brain Injury
用于治疗创伤性脑损伤的 Trk 配体
  • 批准号:
    9280751
  • 财政年份:
    2010
  • 资助金额:
    $ 7.58万
  • 项目类别:
p75NTR Ligands for Treament of Traumatic Brain Injury
用于治疗创伤性脑损伤的 p75NTR 配体
  • 批准号:
    8394596
  • 财政年份:
    2009
  • 资助金额:
    $ 7.58万
  • 项目类别:
p75NTR Ligands for Treament of Traumatic Brain Injury
用于治疗创伤性脑损伤的 p75NTR 配体
  • 批准号:
    7919403
  • 财政年份:
    2009
  • 资助金额:
    $ 7.58万
  • 项目类别:
p75NTR Ligands for Treament of Traumatic Brain Injury
用于治疗创伤性脑损伤的 p75NTR 配体
  • 批准号:
    8195893
  • 财政年份:
    2009
  • 资助金额:
    $ 7.58万
  • 项目类别:
p75NTR Ligands for Treament of Traumatic Brain Injury
用于治疗创伤性脑损伤的 p75NTR 配体
  • 批准号:
    7795053
  • 财政年份:
    2009
  • 资助金额:
    $ 7.58万
  • 项目类别:
STRESS GENES IN BRAIN ISCHEMIA
脑缺血中的应激基因
  • 批准号:
    2259702
  • 财政年份:
    1993
  • 资助金额:
    $ 7.58万
  • 项目类别:
STRESS GENES IN BRAIN ISCHEMIA
脑缺血中的应激基因
  • 批准号:
    2259701
  • 财政年份:
    1993
  • 资助金额:
    $ 7.58万
  • 项目类别:

相似海外基金

Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.58万
  • 项目类别:
    Research Grant
Development of a humanised delivery system for interleukin 2 to treat traumatic brain injury
开发白细胞介素2人源化递送系统来治疗创伤性脑损伤
  • 批准号:
    MR/X029166/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.58万
  • 项目类别:
    Research Grant
Who is Caring for the Caregiver? Understanding Quality of Life and Mental Health Outcomes in Caregivers of Persons with Brain Injury
谁在照顾看护者?
  • 批准号:
    492369
  • 财政年份:
    2023
  • 资助金额:
    $ 7.58万
  • 项目类别:
    Operating Grants
A PROGRESS-Driven Approach to Cognitive Outcomes after Traumatic Brain Injury: Advancing Equity, Diversity, and Inclusion through Knowledge Synthesis and Mobilization
创伤性脑损伤后认知结果的进步驱动方法:通过知识合成和动员促进公平、多样性和包容性
  • 批准号:
    492338
  • 财政年份:
    2023
  • 资助金额:
    $ 7.58万
  • 项目类别:
    Operating Grants
Advancing equity in traumatic brain injury care: A stakeholder-informed meeting on screening for traumatic brain injury in underserved populations
促进创伤性脑损伤护理的公平性:关于在服务不足的人群中筛查创伤性脑损伤的利益相关者知情会议
  • 批准号:
    487815
  • 财政年份:
    2023
  • 资助金额:
    $ 7.58万
  • 项目类别:
    Miscellaneous Programs
Targeting Ryanodine Receptor 2 for Treating Neonatal Hypoxic-ischemic Brain Injury (HIBI)
靶向 Ryanodine 受体 2 治疗新生儿缺氧缺血性脑损伤 (HIBI)
  • 批准号:
    488816
  • 财政年份:
    2023
  • 资助金额:
    $ 7.58万
  • 项目类别:
    Operating Grants
Blood biomarkers to detect brain injury due to intimate partner violence
血液生物标志物可检测亲密伴侣暴力造成的脑损伤
  • 批准号:
    486950
  • 财政年份:
    2023
  • 资助金额:
    $ 7.58万
  • 项目类别:
    Operating Grants
Neuromodulation for impulsivity and suicidality in Veterans with mildtraumatic brain injury and common co-occurring mental health conditions
神经调节对患有轻度脑损伤和常见并发心理健康状况的退伍军人的冲动和自杀倾向
  • 批准号:
    10640567
  • 财政年份:
    2023
  • 资助金额:
    $ 7.58万
  • 项目类别:
Combinatorial Neuroprotective Strategies for Preterm Brain Injury
早产儿脑损伤的组合神经保护策略
  • 批准号:
    10798705
  • 财政年份:
    2023
  • 资助金额:
    $ 7.58万
  • 项目类别:
Oxidative Lipidomics in Pediatric Traumatic Brain Injury
氧化脂质组学在小儿创伤性脑损伤中的应用
  • 批准号:
    10844023
  • 财政年份:
    2023
  • 资助金额:
    $ 7.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了